Ascendis Pharma A/s · NASDAQ:ASND

T. Rowe Price Investment Management, Inc. reported a 9.90% stake in Ascendis Pharma A/s (Schedule 13G)

Event Mar 31, 2026 · Filed May 7, 2026

T. Rowe Price Investment Management, Inc. reported a 9.90% stake in Ascendis Pharma A/s, 6,162,042 shares, as a passive investor on Mar 31, 2026. Filed May 7, 2026 (Schedule 13G).

Stake
9.90%
Shares
6,162,042
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.9.90%6,162,042

Source

View original at SEC

Related